<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Lactulose: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Lactulose: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Lactulose: Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="10786" href="/d/html/10786.html" rel="external">see "Lactulose: Patient drug information"</a> and <a class="drug drug_pediatric" data-topicid="13405" href="/d/html/13405.html" rel="external">see "Lactulose: Pediatric drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F186541"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Constulose;</li>
<li>Enulose;</li>
<li>Generlac;</li>
<li>Kristalose</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F186584"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Ammonium Detoxicant;</li>
<li>
                        Laxative, Osmotic</li></ul></div>
<div class="block doa drugH1Div" id="F186545"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="5cf5683d-351d-423d-a054-afa1e6798e5c">Constipation</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Constipation:</b>
<b>Oral:</b> 10 to 20 g (15 to 30 mL or 1 to 2 packets) daily; may increase to 40 g (60 mL or 2 to 4 packets) daily if necessary.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="642e4653-1ebe-404d-bff9-bf03c8990b70">Hepatic encephalopathy, treatment or prevention</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Hepatic encephalopathy, treatment or prevention:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<i>
<b>Prevention: </b></i></p>
<p style="text-indent:-2em;margin-left:6em;">
<b> Note:</b> May consider as chronic therapy for the prevention of recurrent hepatic encephalopathy with or without other therapies (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25042402']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25042402'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">
<b>Oral:</b> 20 to 30 g (30 to 45 mL) 2 to 4 times daily; may adjust dose every 1 to 2 days to achieve 2 to 3 soft stools/day (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-22710579','lexi-content-ref-Manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-22710579','lexi-content-ref-Manu.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>
<b>Treatment: </b></i></p>
<p style="text-indent:-2em;margin-left:6em;">
<b>Note: </b>Identify and treat precipitating factors. May use as monotherapy for initial treatment or in combination with other therapies when initial monotherapy is unsuccessful. Not recommended for routine treatment of minimal hepatic encephalopathy; may consider on a case-by-case basis in patients with decreased quality of life (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25042402','lexi-content-ref-17326150']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25042402','lexi-content-ref-17326150'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">
<b>Oral:</b> Initial: 20 to 30 g (30 to 45 mL) every 1 to 2 hours to induce ~2 soft stools/day, then reduce to 20 to 30 g (30 to 45 mL) 2 to 4 times daily; may adjust dose every 1 to 2 days to achieve 2 to 3 soft stools/day (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25042402','lexi-content-ref-Ferenci.1','lexi-content-ref-Manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25042402','lexi-content-ref-Ferenci.1','lexi-content-ref-Manu.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">
<b>Rectal (alternative route):</b> Retention enema: 200 g (300 mL) in 700 mL NS or water, retain for 30 to 60 minutes; may repeat every 4 to 8 hours based on responsiveness to therapy. <b>Note: </b>Once patient can tolerate oral administration, consider transition to oral formulation (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-3301614','lexi-content-ref-Manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-3301614','lexi-content-ref-Manu.1'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50991805"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">The renal dosing recommendations are based upon the best available evidence and clinical expertise. Senior Editorial Team: Bruce Mueller, PharmD, FCCP, FASN, FNKF; Jason A. Roberts, PhD, BPharm (Hons), B App Sc, FSHP, FISAC; Michael Heung, MD, MS.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Altered kidney function:</b> No dosage adjustment necessary for any degree of kidney impairment (systemic absorption limited) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Expert.DOR']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Expert.DOR'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Hemodialysis, intermittent (thrice weekly):</b> No supplemental dose or dosage adjustment necessary (systemic absorption limited) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Expert.DOR']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Expert.DOR'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Peritoneal dialysis:</b> No dosage adjustment necessary (systemic absorption limited) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Expert.DOR']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Expert.DOR'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>CRRT: </b>No dosage adjustment necessary (systemic absorption limited) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Expert.DOR']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Expert.DOR'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>PIRRT (eg, sustained, low-efficiency diafiltration): </b>No dosage adjustment necessary (systemic absorption limited) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Expert.DOR']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Expert.DOR'])">Ref</a></span>).</p></div>
<div class="block doha drugH1Div" id="F50989081"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doe drugH1Div" id="F186546"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block dop drugH1Div" id="F186566"><span class="drugH1">Dosing: Pediatric</span><p>(For additional information <a class="drug drug_pediatric" data-topicid="13405" href="/d/html/13405.html" rel="external">see "Lactulose: Pediatric drug information"</a>)</p>
<p style="text-indent:0em;display:inline">
<b>Note:</b> Doses in pediatric patients may be expressed in volume (mL) or weight (g); use extra caution. Oral solution contains 10 g lactulose per 15 mL; packets contain 10 g or 20 g per packet.</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="5cf5683d-351d-423d-a054-afa1e6798e5c">Constipation</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Constipation:</b> Limited data available: Infants, Children, and Adolescents: Oral solution (10 g per 15 mL): Oral: 0.667 to 2 g/kg/day (1 to 3 mL/kg/day) divided once or twice daily; maximum daily dose: 60 g/<b>day</b> (90 mL/<b>day</b>) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23204909','lexi-content-ref-30383579','lexi-content-ref-24345831','lexi-content-ref-Manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23204909','lexi-content-ref-30383579','lexi-content-ref-24345831','lexi-content-ref-Manu.1'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="059d33a1-128f-409c-9da2-ac26ce1baaf6">Constipation, palliative care</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Constipation, palliative care:</b> Limited data available: Children and Adolescents: Oral solution (10 g per 15 mL): Oral: 2 to 30 mL every 6 to 24 hours (Johnston 2005); others have suggested 5 to 10 mL every 2 hours until bowel movement (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Kliegman.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Kliegman.1'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="9f2ca543-9010-4ed3-8271-0df1abcf133d">Portal systemic encephalopathy, prevention</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Portal systemic encephalopathy, prevention (PSE):</b> Oral solution (10 g per 15 mL):</p>
<p style="text-indent:-2em;margin-left:4em;">Infants: Oral: 1.7 to 6.7 g/day (2.5 to 10 mL/day) in divided doses; adjust dosage to produce 2 to 3 stools/day.</p>
<p style="text-indent:-2em;margin-left:4em;">Children and Adolescents: Oral: 26.7 to 60 g/day (40 to 90 mL/day) in divided doses; adjust dosage to produce 2 to 3 stools/day.</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51114948"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in manufacturer's labeling.</p></div>
<div class="block dohp drugH1Div" id="F51114949"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in manufacturer's labeling.</p></div>
<div class="block adr drugH1Div" id="F186515"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;">Postmarketing: Gastrointestinal: Abdominal cramps (Passmore 1993), abdominal distention (Barish 2010), abdominal distress, abdominal pain (Barish 2010), anorexia (Passmore 1993), bloating (Hudson 2019), diarrhea (Hudson 2019), eructation, flatulence (Kang 2021), nausea (Kang 2021), vomiting (Barish 2010)</p></div>
<div class="block coi drugH1Div" id="F186530"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Patients requiring a low galactose diet</p></div>
<div class="block war drugH1Div" id="F186512"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Electrolyte imbalance: Monitor periodically for electrolyte imbalance when lactulose is used &gt;6 months or in patients predisposed to electrolyte abnormalities (eg, elderly, debilitated patients). Hepatic disease may predispose patients to electrolyte imbalance. Infants receiving lactulose may develop hyponatremia and dehydration.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Disease-related concerns:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Diabetes: Use with caution in patients with diabetes mellitus; solution contains galactose and lactose.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Electrocautery procedures: During proctoscopy or colonoscopy procedures involving electrocautery, a theoretical risk of reaction between H<sub>2</sub> gas accumulation and electrical spark may exist; thorough bowel cleansing with a nonfermentable solution is recommended.</p></div>
<div class="block add-pediatric-warn-info drugH1Div" id="F52878512"><span class="drugH1">Warnings: Additional Pediatric Considerations</span>
<p style="text-indent:0em;display:inline">Electrolyte imbalances may occur with chronic use or in patients predisposed to electrolyte imbalances including infants; infants may also develop dehydration with hyponatremia.</p></div>
<div class="block foc drugH1Div" id="F186523"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Packet, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Kristalose: 10 g (30 ea); 20 g (30 ea)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 10 g (15 ea)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Constulose: 10 g/15 mL (237 mL, 946 mL) [unflavored flavor]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Enulose: 10 g/15 mL (473 mL) [unflavored flavor]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generlac: 10 g/15 mL (473 mL, 1892 mL) [unflavored flavor]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 10 g/15 mL (15 mL, 30 mL, 237 mL, 473 mL, 946 mL); 20 g/30 mL (30 mL)</p></div>
<div class="block geq drugH1Div" id="F186508"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F186532"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Pack</b> (Kristalose Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">10 g (per each): $11.54</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">20 g (per each): $11.96</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Pack</b> (Lactulose Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">10 g (per each): $59.92</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Lactulose Encephalopathy Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">10 g/15 mL (per mL): $0.07</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Lactulose Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">10 g/15 mL (per mL): $0.05 - $0.07</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block adm drugH1Div" id="F186527"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Oral solution:</b> May mix with fruit juice, water or milk.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Crystals for oral solution:</b> Dissolve contents of packet in 120 mL water.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Rectal:</b> Dilute with 700 mL of water or NS; administer as retention enema using a rectal balloon catheter; retain for 30 to 60 minutes. May repeat enema immediately if inadvertently evacuated too promptly. Cleansing enemas containing soapsuds or other alkaline agents should not be used.</p></div>
<div class="block admp drugH1Div" id="F52613122"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Oral:</p>
<p style="text-indent:-2em;margin-left:2em;">Oral solution: May mix with fruit juice, water, or milk.</p>
<p style="text-indent:-2em;margin-left:2em;">Crystals for oral solution: Dissolve contents of packet in 120 mL water.</p></div>
<div class="block use drugH1Div" id="F186526"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:-2em;margin-left:2em;margin-right:2em;">
<b>Constipation (Constulose, Kristalose):</b> Treatment of constipation.</p>
<p style="text-indent:-2em;margin-left:2em;margin-right:2em;">
<b>Hepatic encephalopathy (Enulose, Generlac):</b> Treatment and prevention of recurrence of hepatic encephalopathy.</p></div>
<div class="block mst drugH1Div" id="F186591"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues: </span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Lactulose may be confused with lactose</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F13299571"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F186517"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Dichlorphenamide: Laxatives may enhance the hypokalemic effect of Dichlorphenamide. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Glutamine: May diminish the therapeutic effect of Lactulose. Specifically, glutamine may diminish the ammonia-lowering effects of lactulose.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Vitamin K Antagonists (eg, warfarin): Lactulose may enhance the anticoagulant effect of Vitamin K Antagonists. <i> Risk C: Monitor therapy</i></p></div>
<div class="block pri drugH1Div" id="F13763432"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Lactulose is poorly absorbed following oral administration. Treatment of constipation in pregnant women is similar to that of nonpregnant patients and medications may be used when diet and lifestyle modifications are not effective. Lactulose may be used when an osmotic laxative is needed (Body 2016; Gomes 2018; Shin 2015).</p></div>
<div class="block brc drugH1Div" id="F21963781"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:-2em;margin-left:2em;">It is not known if lactulose is present in breast milk; however, lactulose is poorly absorbed following oral administration.</p>
<p style="text-indent:-2em;margin-left:2em;">The manufacturer recommends that caution be exercised when administering lactulose to nursing women.</p></div>
<div class="block dic drugH1Div" id="F186533"><span class="drugH1">Dietary Considerations</span>
<p style="text-indent:0em;display:inline">Contraindicated in patients on galactose-restricted diet.</p></div>
<div class="block mop drugH1Div" id="F186521"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">BP, standing/supine; serum electrolytes; bowel movement frequency; fluid status; serum ammonia.</p></div>
<div class="block pha drugH1Div" id="F186511"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">The bacterial degradation of lactulose resulting in an acidic pH inhibits the diffusion of NH<sub>3</sub> into the blood by causing the conversion of NH<sub>3</sub> to NH<sub>4</sub>+; also enhances the diffusion of NH<sub>3</sub> from the blood into the gut where conversion to NH<sub>4</sub>+ occurs; produces an osmotic effect in the colon with resultant distention promoting peristalsis; reduces blood ammonia concentration to reduce the degree of portal systemic encephalopathy</p></div>
<div class="block phk drugH1Div" id="F186529"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Onset:</p>
<p style="text-indent:-2em;margin-left:4em;">Constipation: Up to 24 to 48 hours to produce a normal bowel movement</p>
<p style="text-indent:-2em;margin-left:4em;">Encephalopathy: At least 24 to 48 hours</p>
<p style="text-indent:-2em;margin-left:2em;">Absorption: Poor</p>
<p style="text-indent:-2em;margin-left:2em;">Metabolism: Via colonic flora to lactic acid and acetic acid; requires colonic flora for drug activation</p>
<p style="text-indent:-2em;margin-left:2em;">Excretion: Primarily feces; urine (≤3%)</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F186534"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AE)</span> <span class="country">United Arab Emirates</span><span class="countrySeparator">: </span><span class="drugName">Duphalac | Duphalac fruit | Rialac | Soflax</span>;</li>
<li>
<span class="countryCode">(AR)</span> <span class="country">Argentina</span><span class="countrySeparator">: </span><span class="drugName">Lactulon | Medixin | Ronelax</span>;</li>
<li>
<span class="countryCode">(AT)</span> <span class="country">Austria</span><span class="countrySeparator">: </span><span class="drugName">Bifiteral | Lactulose Hexal | Laevolac</span>;</li>
<li>
<span class="countryCode">(AU)</span> <span class="country">Australia</span><span class="countrySeparator">: </span><span class="drugName">Dulose</span>;</li>
<li>
<span class="countryCode">(BD)</span> <span class="country">Bangladesh</span><span class="countrySeparator">: </span><span class="drugName">Actilac | Avolac | Dilax | Dulac | E lax | Ezylax | Lactu | Lax | Laxol | Livax | Loctoz | Lublac | Mebolos | Mylac | Niprolac | Onlac | Osmolax | Relacs | Serelose | Sinalac | Sivolac | Tulac | Tulos</span>;</li>
<li>
<span class="countryCode">(BE)</span> <span class="country">Belgium</span><span class="countrySeparator">: </span><span class="drugName">Bifiteral | Certalac | Duphalac | Lactulose eurogenerics | Lactulose sandoz | Lactulose teva generics belgium</span>;</li>
<li>
<span class="countryCode">(BG)</span> <span class="country">Bulgaria</span><span class="countrySeparator">: </span><span class="drugName">Duphalac</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Lacmax | Lactolinea | Lactu star | Lactudose | Lactugold | Lactulaxy | Lactulife | Lactulona | Lactunat | Laxsotrin | Normalive | Normalize | Raia lactulose | Regulax fibras</span>;</li>
<li>
<span class="countryCode">(CH)</span> <span class="country">Switzerland</span><span class="countrySeparator">: </span><span class="drugName">Legendal</span>;</li>
<li>
<span class="countryCode">(CI)</span> <span class="country">Côte d'Ivoire</span><span class="countrySeparator">: </span><span class="drugName">Laxatose</span>;</li>
<li>
<span class="countryCode">(CL)</span> <span class="country">Chile</span><span class="countrySeparator">: </span><span class="drugName">Dismam | Lactulosa | Laevolac</span>;</li>
<li>
<span class="countryCode">(CN)</span> <span class="country">China</span><span class="countrySeparator">: </span><span class="drugName">Dani-lactulose | Danilax | Duphalac | Laevolac | Li dong</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">Constilax | Duphalac | Lactulax | Lactulen | Lactunova | Laxilose</span>;</li>
<li>
<span class="countryCode">(CZ)</span> <span class="country">Czech Republic</span><span class="countrySeparator">: </span><span class="drugName">Laktulosa Sandoz</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Bifinorma | Bifiteral | Kattwilact | Lactocur | Lactofalk | Lactuflor | Lactulade | Lactulose Saar | Lactulose stada | Lactuverlan</span>;</li>
<li>
<span class="countryCode">(DK)</span> <span class="country">Denmark</span><span class="countrySeparator">: </span><span class="drugName">Medilax</span>;</li>
<li>
<span class="countryCode">(DO)</span> <span class="country">Dominican Republic</span><span class="countrySeparator">: </span><span class="drugName">Constulosa | Laansalax | Lactulosa | Lactulosa ABL</span>;</li>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Axant | Beralactulosa | Lactulax | Lactulosa | Oxialac</span>;</li>
<li>
<span class="countryCode">(EE)</span> <span class="country">Estonia</span><span class="countrySeparator">: </span><span class="drugName">Duphalac | Duphalac fruit | Lactulose Rathiopharm</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">Lactoline</span>;</li>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">Belmalax | Duphalac | Lactulosa Lainco | Lactulosa llorente | Lactulosa resolution</span>;</li>
<li>
<span class="countryCode">(ET)</span> <span class="country">Ethiopia</span><span class="countrySeparator">: </span><span class="drugName">Laxalink</span>;</li>
<li>
<span class="countryCode">(FI)</span> <span class="country">Finland</span><span class="countrySeparator">: </span><span class="drugName">Duphalac | Duphalac fruit | Lactulos ratiophararm | Lactulose sandoz | Levolac | Loraga</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Duphalac | Lactulose biogaran | Lactulose biphar | Lactulose g gam | Lactulose irex | Lactulose ivax | Lactulose merck | Lactulose qualimed | Lactulose rpg</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Duphalac | Gatinar | Lactolax | Lactugal | Lactulose aps | Lactulose berk | Lactulose cox | Lactulose kent | Lactulose novartis | Lactulose sandoz | Lemlax</span>;</li>
<li>
<span class="countryCode">(GR)</span> <span class="country">Greece</span><span class="countrySeparator">: </span><span class="drugName">Duphalac</span>;</li>
<li>
<span class="countryCode">(HK)</span> <span class="country">Hong Kong</span><span class="countrySeparator">: </span><span class="drugName">Duphalac | Madame pearl's mp lactulose | Pms Lactulose</span>;</li>
<li>
<span class="countryCode">(HU)</span> <span class="country">Hungary</span><span class="countrySeparator">: </span><span class="drugName">Duphalac | Laevolac-laktuloz</span>;</li>
<li>
<span class="countryCode">(ID)</span> <span class="country">Indonesia</span><span class="countrySeparator">: </span><span class="drugName">Constipen</span>;</li>
<li>
<span class="countryCode">(IE)</span> <span class="country">Ireland</span><span class="countrySeparator">: </span><span class="drugName">Duphalac</span>;</li>
<li>
<span class="countryCode">(IL)</span> <span class="country">Israel</span><span class="countrySeparator">: </span><span class="drugName">Laevolac</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">Agilax | Bestoloos | Biolac | Biomaze | Bowlease | Cadilose | Duphalac | Duphalac fiber | Eldoluc | Emty | Esivac | Evalex | Evict | Gentalose | Gush | Heptulac | Ibflux | Inluse | Lacsan | Lactiv | Lactolyfe | Lactusoft | Laxan | Laxiforce | Laxil | Laxit L | Laxolin | Laxoluz | Laxose | Laxulose | Livintact-ev | Livoluk | Looz | Loozsun | Loozylax | Lose it | Mt lac | Mtlac | Normalac | Nostipan | Nulax | Osmowin | Purolac | Rapiduce | Reevac | Smulax | Swiftolac | Swilac | Uzupas</span>;</li>
<li>
<span class="countryCode">(IQ)</span> <span class="country">Iraq</span><span class="countrySeparator">: </span><span class="drugName">Acelac</span>;</li>
<li>
<span class="countryCode">(IT)</span> <span class="country">Italy</span><span class="countrySeparator">: </span><span class="drugName">Biolac eps | Dia colon | Dia colon eps | Duphalac | Epalfen | Epalfen eps | Lactoger | Laevolac | Laevolac eps | Lattulac eps | Lattulosio | Lis eps | Osmolac | Osmolac eps</span>;</li>
<li>
<span class="countryCode">(JO)</span> <span class="country">Jordan</span><span class="countrySeparator">: </span><span class="drugName">Duphalac</span>;</li>
<li>
<span class="countryCode">(JP)</span> <span class="country">Japan</span><span class="countrySeparator">: </span><span class="drugName">Lactulose Kowa Soyaku | Lactulose nikken | Monilac | Piarle</span>;</li>
<li>
<span class="countryCode">(KE)</span> <span class="country">Kenya</span><span class="countrySeparator">: </span><span class="drugName">Avolac | Duphalac | Inolac | Lactitoss | Laxolac | Osmolax | Osmowin | Relax | Tulac</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Duphalac | Jangqerac</span>;</li>
<li>
<span class="countryCode">(KW)</span> <span class="country">Kuwait</span><span class="countrySeparator">: </span><span class="drugName">Duphalac | Rialac</span>;</li>
<li>
<span class="countryCode">(LB)</span> <span class="country">Lebanon</span><span class="countrySeparator">: </span><span class="drugName">Duphalac</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Duphalac | Duphalac fruit | Lactulose ratiopharm</span>;</li>
<li>
<span class="countryCode">(LU)</span> <span class="country">Luxembourg</span><span class="countrySeparator">: </span><span class="drugName">Certalac | Duphalac</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Duphalac | Duphalac fruit | Lactulose ratiopharm</span>;</li>
<li>
<span class="countryCode">(MA)</span> <span class="country">Morocco</span><span class="countrySeparator">: </span><span class="drugName">Duphalac | Lactulax | Laevolac | Osmolax</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">Lactulosa | Regulact</span>;</li>
<li>
<span class="countryCode">(MY)</span> <span class="country">Malaysia</span><span class="countrySeparator">: </span><span class="drugName">Consiqare | Duphavid | Laevolac | Osmolax | Unilac | Unilac lactulose</span>;</li>
<li>
<span class="countryCode">(NG)</span> <span class="country">Nigeria</span><span class="countrySeparator">: </span><span class="drugName">Duphalac</span>;</li>
<li>
<span class="countryCode">(NL)</span> <span class="country">Netherlands</span><span class="countrySeparator">: </span><span class="drugName">Duphalac | Legendal</span>;</li>
<li>
<span class="countryCode">(NO)</span> <span class="country">Norway</span><span class="countrySeparator">: </span><span class="drugName">Duphalac | Laktulose | Levolac</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">Lacdol</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Caliral | Constulosa | Lactuclean | Lactufar | Lactulax | Lactulosa | Laxaliv | Laxucar | Laxulosa | Lipebin | Lipelab | Lipelax | Nitardil | Regulax | Zelcom</span>;</li>
<li>
<span class="countryCode">(PH)</span> <span class="country">Philippines</span><span class="countrySeparator">: </span><span class="drugName">Biolac | Duphalac | Lactul</span>;</li>
<li>
<span class="countryCode">(PK)</span> <span class="country">Pakistan</span><span class="countrySeparator">: </span><span class="drugName">Apholac | Duphalac | Lactoger | Lactozaf</span>;</li>
<li>
<span class="countryCode">(PL)</span> <span class="country">Poland</span><span class="countrySeparator">: </span><span class="drugName">Duphalac</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Kristalose</span>;</li>
<li>
<span class="countryCode">(PT)</span> <span class="country">Portugal</span><span class="countrySeparator">: </span><span class="drugName">Duphalac | Lactulose sandoz</span>;</li>
<li>
<span class="countryCode">(PY)</span> <span class="country">Paraguay</span><span class="countrySeparator">: </span><span class="drugName">Drenabyl | Laxosan | Promelac</span>;</li>
<li>
<span class="countryCode">(QA)</span> <span class="country">Qatar</span><span class="countrySeparator">: </span><span class="drugName">Duphalac | Duphalac Fruit | Duphalac Sticks | Ezilax | Kulax Syrup | Lact-Q | Laxodad | Laxolac | Ramlac | Rialac | Sedalac</span>;</li>
<li>
<span class="countryCode">(RO)</span> <span class="country">Romania</span><span class="countrySeparator">: </span><span class="drugName">Duphalac | Duphalac fruit | Lactecon | Lactulak</span>;</li>
<li>
<span class="countryCode">(RU)</span> <span class="country">Russian Federation</span><span class="countrySeparator">: </span><span class="drugName">Duphalac</span>;</li>
<li>
<span class="countryCode">(SA)</span> <span class="country">Saudi Arabia</span><span class="countrySeparator">: </span><span class="drugName">Duphalac</span>;</li>
<li>
<span class="countryCode">(SE)</span> <span class="country">Sweden</span><span class="countrySeparator">: </span><span class="drugName">Betulac | Betulac Apelsin | Duphalac | Duphalac Frukt | Lactulose arrow | Laktipex | Laktulos Abbott | Laktulos Apelsin Meda | Laktulos apelsin pharmacia | Laktulos Apelsin Recip | Laktulos MIP | Laktulos pharmacia | Laktulos Recip | Laktulos Tika | Loraga | Osmolac</span>;</li>
<li>
<span class="countryCode">(SG)</span> <span class="country">Singapore</span><span class="countrySeparator">: </span><span class="drugName">Dhactulose | Duphalac</span>;</li>
<li>
<span class="countryCode">(SI)</span> <span class="country">Slovenia</span><span class="countrySeparator">: </span><span class="drugName">Lactecon</span>;</li>
<li>
<span class="countryCode">(SK)</span> <span class="country">Slovakia</span><span class="countrySeparator">: </span><span class="drugName">Duphalac</span>;</li>
<li>
<span class="countryCode">(TN)</span> <span class="country">Tunisia</span><span class="countrySeparator">: </span><span class="drugName">Duphalac | Laxatyl | Perilax</span>;</li>
<li>
<span class="countryCode">(TR)</span> <span class="country">Turkey</span><span class="countrySeparator">: </span><span class="drugName">Osmolak</span>;</li>
<li>
<span class="countryCode">(TW)</span> <span class="country">Taiwan</span><span class="countrySeparator">: </span><span class="drugName">B-cut | Cosily | Duphalac | Lacoly</span>;</li>
<li>
<span class="countryCode">(UA)</span> <span class="country">Ukraine</span><span class="countrySeparator">: </span><span class="drugName">Duphalac | Duphalac fruit | Lactulax | Laxarin</span>;</li>
<li>
<span class="countryCode">(UG)</span> <span class="country">Uganda</span><span class="countrySeparator">: </span><span class="drugName">Duphalac | Lactease | Osmolax</span>;</li>
<li>
<span class="countryCode">(UY)</span> <span class="country">Uruguay</span><span class="countrySeparator">: </span><span class="drugName">Lactulon | Lactulosa lakinor</span>;</li>
<li>
<span class="countryCode">(VE)</span> <span class="country">Venezuela, Bolivarian Republic of</span><span class="countrySeparator">: </span><span class="drugName">Lactulosa | Moderan</span>;</li>
<li>
<span class="countryCode">(VN)</span> <span class="country">Viet Nam</span><span class="countrySeparator">: </span><span class="drugName">Companity</span>;</li>
<li>
<span class="countryCode">(ZA)</span> <span class="country">South Africa</span><span class="countrySeparator">: </span><span class="drugName">Duphalac | Laxette</span>;</li>
<li>
<span class="countryCode">(ZM)</span> <span class="country">Zambia</span><span class="countrySeparator">: </span><span class="drugName">Lactulin</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-22710579">
<a name="22710579"></a>Agrawal A, Sharma BC, Sharma P, Sarin SK. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy. <i>Am J Gastroenterol</i>. 2012;107(7):1043-1050. doi:10.1038/ajg.2012.113<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lactulose-drug-information/abstract-text/22710579/pubmed" id="22710579" target="_blank">22710579</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21694860">
<a name="21694860"></a>Barish CF, Voss B, Kaelin B. Comparison of preference and safety of powder and liquid lactulose in adult patients with chronic constipation. <i>Clin Exp Gastroenterol</i>. 2010;3:153-158. doi:10.2147/CEG.S13568<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lactulose-drug-information/abstract-text/21694860/pubmed" id="21694860" target="_blank">21694860</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27261898">
<a name="27261898"></a>Body C, Christie JA. Gastrointestinal diseases in pregnancy: nausea, vomiting, hyperemesis gravidarum, gastroesophageal reflux disease, constipation, and diarrhea. <i>Gastroenterol Clin North Am</i>. 2016;45(2):267‐283. doi:10.1016/j.gtc.2016.02.005<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lactulose-drug-information/abstract-text/27261898/pubmed" id="27261898" target="_blank">27261898</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Constulose (lactulose) [prescribing information]. Morristown, NJ: Actavis Inc; January 2011.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Constulose.2">
<a name="Constulose.2"></a>Constulose (lactulose) solution, USP [prescribing information]. Parsippany, NJ: Teva Pharmaceuticals; June 2022.</div>
</li>
<li>
<div class="reference">
                  Enulose (lactulose) [prescribing information]. Morristown, NJ: Actavis Inc; January 2011.</div>
</li>
<li>
<div class="reference">
                  Enulose (lactulose) [prescribing information]. Parsippany, NJ: Actavis Pharma Inc; March 2016.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Enulose.2">
<a name="Enulose.2"></a>Enulose (lactulose) solution, USP [prescribing information]. Parsippany, NJ: Teva Pharmaceuticals; June 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Expert.DOR">
<a name="Expert.DOR"></a>Expert opinion. Senior Renal Editorial Team: Bruce Mueller, PharmD, FCCP, FASN, FNKF; Jason A. Roberts, PhD, BPharm (Hons), B App Sc, FSHP, FISAC; Michael Heung, MD, MS.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Ferenci.1">
<a name="Ferenci.1"></a>Ferenci P. Hepatic encephalopathy in adults: treatment. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed September 2, 2021.</div>
</li>
<li>
<div class="reference">
                  Generlac (lactulose) [prescribing information]. Morton Grove, IL: Morton Grove Pharmaceuticals Inc; January 2014.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29991883">
<a name="29991883"></a>Gomes CF, Sousa M, Lourenço I, Martins D, Torres J. Gastrointestinal diseases during pregnancy: what does the gastroenterologist need to know?. <i>Ann Gastroenterol</i>. 2018;31(4):385‐394. doi:10.20524/aog.2018.0264<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lactulose-drug-information/abstract-text/29991883/pubmed" id="29991883" target="_blank">29991883</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30444745">
<a name="30444745"></a>Hudson M, Schuchmann M. Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence. <i>Eur J Gastroenterol Hepatol</i>. 2019;31(4):434-450. doi:10.1097/MEG.0000000000001311<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lactulose-drug-information/abstract-text/30444745/pubmed" id="30444745" target="_blank">30444745</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30383579">
<a name="30383579"></a>Jarzebicka D, Sieczkowska-Golub J, Kierkus J, et al. PEG 3350 versus lactulose for treatment of functional constipation in children: randomized study. <i>J Pediatr Gastroenterol Nutr</i>. 2019;68(3):318-324. doi:10.1097/MPG.0000000000002192<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lactulose-drug-information/abstract-text/30383579/pubmed" id="30383579" target="_blank">30383579</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23118638">
<a name="23118638"></a>Johnston DL, Hentz TA, Friedman DL. Pediatric palliative care. <i>J Pediatr Pharmacol Ther</i>. 2005;10(4):200-214.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lactulose-drug-information/abstract-text/23118638/pubmed" id="23118638" target="_blank">23118638</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34642269">
<a name="34642269"></a>Kang SJ, Cho YS, Lee TH, et al. Medical management of constipation in elderly patients: systematic review. <i>J Neurogastroenterol Motil</i>. 2021;27(4):495-512. doi:10.5056/jnm20210<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lactulose-drug-information/abstract-text/34642269/pubmed" id="34642269" target="_blank">34642269</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Kliegman.1">
<a name="Kliegman.1"></a>Kliegman RM and St. Geme J, eds. <i>Nelson Textbook of Pediatrics</i>. 21st ed. Saunders Elsevier; 2020.</div>
</li>
<li>
<div class="reference">
                  Kristalose (lactulose) [prescribing information]. Nashville, TN: Cumberland Pharmaceuticals; September 2018.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Kristalose.1">
<a name="Kristalose.1"></a>Kristalose (lactulose) powder for solution [prescribing information]. Nashville, TN: Cumberland Pharmaceuticals Inc; July 2018.</div>
</li>
<li>
<div class="reference">
                  Lactulose [prescribing information]. Amityville, NY: Hi-Tech Pharmacal Co Inc; July 2016.</div>
</li>
<li>
<div class="reference">
                  Lactulose [prescribing information]. Parsippany, NJ: Actavis Pharma Inc; March 2016.</div>
</li>
<li>
<div class="reference">
                  Lactulose Solution [prescribing information]. Amityville, NY: Hi-Tech Pharmacal Co Inc; March 2013.</div>
</li>
<li>
<div class="reference">
                  Lactulose Solution [prescribing information]. Largo, FL: VistaPharm Inc; May 2010.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-2122724">
<a name="2122724"></a>Lederle FA, Busch DL, Mattox KM, et al. Cost-Effective Treatment of Constipation in the Elderly: A Randomized Double-Blind Comparison of Sorbitol and Lactulose. <i>Am J Med</i>. 1990;89(5):597-601.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lactulose-drug-information/abstract-text/2122724/pubmed" id="2122724" target="_blank">2122724</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-8219947">
<a name="8219947"></a>Passmore AP, Wilson-Davies K, Stoker C, Scott ME. Chronic constipation in long stay elderly patients: a comparison of lactulose and a senna-fibre combination. <i>BMJ</i>. 1993;307(6907):769-771. doi:10.1136/bmj.307.6907.769<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lactulose-drug-information/abstract-text/8219947/pubmed" id="8219947" target="_blank">8219947</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17326150">
<a name="17326150"></a>Prasad S, Dhiman RK, Duseja A, et al. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. <i>Hepatology</i>. 2007;45(3):549-559.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lactulose-drug-information/abstract-text/17326150/pubmed" id="17326150" target="_blank">17326150</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Manu.1">
<a name="Manu.1"></a>Refer to manufacturer's labeling.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12381237">
<a name="12381237"></a>Rosholm JU, Nybo H, Andersen Ranberg K, et al. Hyponatraemia in very old nonhospitalised people: association with drug use. <i>Drugs Aging</i>. 2002;19(9):685-693.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lactulose-drug-information/abstract-text/12381237/pubmed" id="12381237" target="_blank">12381237</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23204909">
<a name="23204909"></a>Rowan-Legg A; Canadian Paediatric Society, Community Paediatrics Committee. Managing functional constipation in children. <i>Paediatr Child Health</i>. 2011;16(10):661-670.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lactulose-drug-information/abstract-text/23204909/pubmed" id="23204909" target="_blank">23204909</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25803402">
<a name="25803402"></a>Shin GH, Toto EL, Schey R. Pregnancy and postpartum bowel changes: constipation and fecal incontinence. <i>Am J Gastroenterol</i>. 2015;110(4):521‐530. doi:10.1038/ajg.2015.76<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lactulose-drug-information/abstract-text/25803402/pubmed" id="25803402" target="_blank">25803402</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24345831">
<a name="24345831"></a>Tabbers MM, DiLorenzo C, Berger MY, et al; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition; North American Society for Pediatric Gastroenterology. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. <i>J Pediatr Gastroenterol Nutr</i>. 2014;58(2):258-274.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lactulose-drug-information/abstract-text/24345831/pubmed" id="24345831" target="_blank">24345831</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-3301614">
<a name="3301614"></a>Uribe M, Campollo O, Vargas F, et al. Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal-systemic encephalopathy: a double-blind, randomized clinical trial. <i>Hepatology</i>. 1987;7(4):639-643. doi:10.1002/hep.1840070404<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lactulose-drug-information/abstract-text/3301614/pubmed" id="3301614" target="_blank">3301614</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25042402">
<a name="25042402"></a>Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. <i>Hepatology</i>. 2014;60(2):715-735.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lactulose-drug-information/abstract-text/25042402/pubmed" id="25042402" target="_blank">25042402</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 9543 Version 362.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
